{"id":"W2338840013","doi":"10.1212/wnl.86.16_supplement.p3.169","title":"A Phase II Trial to Assess the Efficacy, Safety and Feasibility of 20[percnt] Subcutaneous Immunoglobulin in Patients with Myasthenia Gravis Exacerbation - Trial Design (P3.169)","year":2016,"lang":"en","type":"article","venue":"Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Exacerbation; Myasthenia gravis; Medicine; Clinical trial; Adverse effect; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003833232,0.001975675,0.001957025,0.0003557678,0.0005050672,0.0007283568,0.0009784106,0.00196166,0.0078809],"category_scores_gemma":[0.00176472,0.0004808926,0.00115888,0.0002900275,0.001037025,0.0009685147,0.0004906342,0.003152527,0.001478933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007254975,"about_ca_system_score_gemma":0.002061564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000506768,"about_ca_topic_score_gemma":0.001100545,"domain_scores_codex":[0.9987208,0.0008523163,0.00005489243,0.0001493882,0.00007120075,0.0001513608],"domain_scores_gemma":[0.998516,0.000307201,0.0003324509,0.000111077,0.00008840051,0.0006448308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9346874,0.03153387,0.002190712,0.000481924,0.0003295378,0.0001348276,0.00009387356,0.0005505209,0.006986138,0.0002273688,0.001772513,0.02101119],"study_design_scores_gemma":[0.790336,0.2064509,0.001616057,0.00001364666,0.00006129759,0.00006384703,0.000009876659,0.0003556266,0.00034643,0.00009730136,0.0006393307,0.000009668481],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9672435,0.001490666,0.001275051,0.0009824859,0.0003310078,0.02374642,0.001778321,0.000144162,0.003008285],"genre_scores_gemma":[0.947784,0.0009647509,0.007080598,0.002881814,0.0007206053,0.0327355,0.003543949,0.00004022484,0.00424861],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.0078809,"threshold_uncertainty_score":0.02636421,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04089064036870921,"score_gpt":0.3045636919832562,"score_spread":0.263673051614547,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}